Escalon Medical CORP 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OQB
Escalon Medical Corp. reported a significantly wider net loss for Q1 2026, alongside ongoing concerns about its ability to continue as a going concern and ineffective disclosure controls.
OQB
Escalon Medical Corp. reports increased revenue and a net income for the quarter ended March 31, 2025, marking a positive shift from the previous year's loss.
OQB
Escalon Medical Corp. reports increased net revenue and a profitable quarter, driven by growth in Trek's gas products, as detailed in their Form 10-Q filing for the period ended December 31, 2024.
OQB
Escalon Medical Corp. experienced a 5.6% decrease in net revenue for the quarter ended September 30, 2024, primarily due to lower ultrasound product sales, partially offset by increased gas product sales.
OQB
Escalon Medical Corp. experienced a decrease in net revenue and a net loss for the quarter ended March 31, 2024, while also facing ongoing concerns about its ability to continue as a going concern.
OQB
Escalon Medical Corp. saw a slight increase in revenue for the six months ended December 31, 2023, but continues to face financial challenges and going concern issues.